The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers

被引:82
|
作者
Mwaura, B
Mahendran, B
Hynes, N
Defreitas, D
Avalos, G
Adegbola, T
Adharn, M
Connolly, CE
Sultan, S [1 ]
机构
[1] Univ Coll Hosp Galway, Western Vasc Inst, Dept Vasc & Endovasc Surg, Galway, Ireland
[2] Univ Coll Hosp Galway, Western Vasc Inst, Dept Pathol, Galway, Ireland
关键词
matrix metalloproteinase inducer; matrix metalloproteinase-2; tissue inhibitors of matrix metalloproteinases; platelet derived growth factor; venous ulcer;
D O I
10.1016/j.ejvs.2005.08.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction. Alteration in the expression of extracellular matrix metalloproteinase inducer (EMMPRIN), matrix metalloproteinase-2 (MMP-2), tissue inhibitors of matrix metalloproteinases (TIMP-2) and platelet derived growth factor (PDGF-AA) may contribute to poor healing in venous leg ulcers. Aim. The aim of this study is to determine the expression of EMMPRIN, MMP-2, TIMP-2 and PDGF-AA in the ulcer exudates and perivascular tissue of healing and non-healing chronic venous ulcers. Patients, materials and methods. Forty patients with chronic venous ulcers were included in this study, with a mean age of 60 years. Eleven patients were males and 29 were females. All patients had normal ankle brachial index and a venous ulcer of at least 8 weeks duration. Immuno-histochemistry using monoclonal antibodies to PDGF-AA, MMP-2, TIMP-2 and EMMPRIN was carried out on paraffin embedded punch biopsy skin specimens from the ulcer edge. Enzyme linked immunosorbent assay for PDGF, MMP2 and TIMP-2 were carried out on wound fluids collected from patients. The ulcer size and character at the initial assessment and after 8 weeks were assessed to determine the status of ulcer healing. Results. No significant difference was seen in the expression of TIMP-2, MMP-2 and EMMPRIN between the two groups. However, in the non-healing group high levels of MMP-2 and low levels of TIMP-2 in the wound fluid suggest a strong correlation of these two markers in the state of healing. Analysis of wound fluid by ELISA demonstrated high PDGF-AA in the healing group (p = 0.021). Significantly increased levels of PDGF-AA (p < 0001) was noted in the perivascular area on immuno-histochemistry of healing ulcers. These data suggest that PDGF-AA plays an important role in healing of venous ulcers. Conclusion. Non-healing venous ulcers are associated with greater activity MMP-2 activity. The ratio of MMPs to their inhibitors TIMPs, dictate the rate of healing of the ulcers. PDGF-AA activity is associated with ulcer healing, though the mechanism is unclear. EMMPRIN expression in chronic venous ulcers probably parallels the chronicity of the condition rather than propagate it. However, further studies with larger samples are needed.
引用
收藏
页码:306 / 310
页数:5
相关论文
共 50 条
  • [1] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [2] The impact of expression of extracellular matrix metalloproteinase inducer (EMMPRIN), matrix metalloproteinase-2 (MMP-2), tissue inhibitors of matrix metalloproteinases (TIMP-2) on the chronicity of venous leg ulcers. Does matrix metalloproteinase alter healing?
    Mwaura, B
    Defreitas, D
    Avalos, G
    Adegbola, T
    Adham, M
    Courtney, D
    Connoly, P
    Sultan, S
    BRITISH JOURNAL OF SURGERY, 2004, 91 : 13 - 14
  • [3] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    ORAL ONCOLOGY, 2011, 47 : S84 - S84
  • [4] Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions
    Caudroy, S
    Polette, M
    Tournier, JM
    Burlet, H
    Toole, B
    Zucker, S
    Birembaut, P
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (12) : 1575 - 1580
  • [5] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [6] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [7] Mitogenic bovine whey extract modulates matrix metalloproteinase-2,-9, and tissue inhibitor of matrix metalloproteinase-2 levels in chronic leg ulcers
    Varelias, A
    Cowin, AJ
    Adams, D
    Harries, RHC
    Cooter, RD
    Belford, DA
    Fitridge, RA
    Rayner, TE
    WOUND REPAIR AND REGENERATION, 2006, 14 (01) : 28 - 37
  • [8] Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
    Kanayama, H
    Yokota, K
    Kurokawa, Y
    Murakami, Y
    Nishitani, M
    Kagawa, S
    CANCER, 1998, 82 (07) : 1359 - 1366
  • [9] Effects of valsartan on matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in atrial fibrillation patients
    裴晓阳
    潘莹
    颜雯
    胡雪松
    SouthChinaJournalofCardiology, 2010, 11 (01) : 15 - 19
  • [10] Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
    Kang, Shan
    Zhao, Xiwa
    Xing, Huimin
    Wang, Na
    Zhou, Rongmiao
    Chen, Shucheng
    Li, Wansheng
    Zhao, Jian
    Duan, Yanan
    Sun, Donglan
    Li, Yan
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (03) : 226 - 231